Skip to content
Back to Guavy Wire
Stocks

UnitedHealth Covers Crucial Blood Test for Colorectal Cancer Screening

Instruments
UNH
Share

A recent development in Pennsylvania's healthcare landscape is giving cancer patients and their families hope. UnitedHealth Group, the nation's largest health insurer, has added Guardant Health's Shield blood test to its list of covered services for colorectal cancer screening.

This move follows Medicare's lead, which already covers the test for nearly 3 million Pennsylvanians. The test is crucial in catching colorectal cancer early, as it has a five-year survival rate of 91 percent when detected early compared to a sharply lower rate when diagnosed late.

Colorectal cancer claimed the life of one father in 2011 and is estimated to take roughly 2,240 neighbors this year. The author of the letter to the editor, who is currently undergoing treatment for cancer, highlights the importance of timely detection and coverage of such tests by health insurers.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc